Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus May

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Translational Science|August 11, 2025
First-In-Human, Randomized, Placebo-Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy AdultsMarcus May, Julia K Bialek-Waldmann, Andrew Wright, et al.
Scientific Reports|May 19, 2018
Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activationKristine Chobanyan-Jürgens, Karsten Heusser, David Duncker, et al.
Thrombosis and Haemostasis|December 31, 2019
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia AAndreas Tiede, Ana Rosa Cid, Georg Goldmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical StudyAlexandra M Blossey, Sina Brückner, Marcus May, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?Carina Jarzimski, Matthias Karst, Alexander A Zoerner, et al.
Journal of Patient-Reported Outcomes|January 7, 2026
Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative studyCourtney N Hurt, Maja Kuharic, Sara Shaunfield, et al.
Journal of the American Society of Hypertension : JASH|July 2, 2017
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertensionStefan Engeli, Marcus May, Juerg Nussberger, et al.
Journal of the American Heart Association|January 15, 2016
Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular PhenotypingKarsten Heusser, Jens Tank, Julia Brinkmann, et al.
Vaccine|October 12, 2023
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in GermanyInci Aydin, Marcus May, Fabio Pisano, et al.
Plos One|October 22, 2011
Liver afferents contribute to water drinking-induced sympathetic activation in human subjects: a clinical trialMarcus May, Faikah Gueler, Hannelore Barg-Hock, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Translational Science|August 11, 2025
First-In-Human, Randomized, Placebo-Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy AdultsMarcus May, Julia K Bialek-Waldmann, Andrew Wright, et al.
Scientific Reports|May 19, 2018
Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activationKristine Chobanyan-Jürgens, Karsten Heusser, David Duncker, et al.
Thrombosis and Haemostasis|December 31, 2019
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia AAndreas Tiede, Ana Rosa Cid, Georg Goldmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical StudyAlexandra M Blossey, Sina Brückner, Marcus May, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?Carina Jarzimski, Matthias Karst, Alexander A Zoerner, et al.
Journal of Patient-Reported Outcomes|January 7, 2026
Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative studyCourtney N Hurt, Maja Kuharic, Sara Shaunfield, et al.
Journal of the American Society of Hypertension : JASH|July 2, 2017
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertensionStefan Engeli, Marcus May, Juerg Nussberger, et al.
Journal of the American Heart Association|January 15, 2016
Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular PhenotypingKarsten Heusser, Jens Tank, Julia Brinkmann, et al.
Vaccine|October 12, 2023
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in GermanyInci Aydin, Marcus May, Fabio Pisano, et al.
Plos One|October 22, 2011
Liver afferents contribute to water drinking-induced sympathetic activation in human subjects: a clinical trialMarcus May, Faikah Gueler, Hannelore Barg-Hock, et al.
Pageof 4